StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
AHF.AX$0.02-5.00%
Fair $0.02+0.0%

AHF.AX

Australian Dairy Nutritionals Limited

Consumer Defensive / Packaged FoodsASX

$0.02

-0.00 (-5.00%)

Fairly Valued+0.0%Fair Value $0.02Fund rank 31/100 · Data gapFallback financials|
SA 15/F
F-Score: 5/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 24%

FCF escenarios

weak_data · normalized FCF $-4.7M · quality 70.3/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 34/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

15/100

F

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -21.8%, below the 5% threshold
Thesis & Journal · AHF.AXLocal privado en este navegador · Australian Dairy Nutritionals Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$14M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-21.8%

↓

Gross Margin

-19.8%

↓

Debt/Equity

0.00

↓
52-Week Range$0
$0$0

TradingView lightweight chart

AHF.AX price, volumen y niveles de valoración

Último $0.019Periodo -95.7%
Fair value: $0.019

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-21.6%

FCF CAGR

—

FCF margin

-48.3%

FCF / Net income

0.67x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $7.2M · net income $-5.2M · FCF $-3.5M

2022-FY → 2025-FY

Gross margin

-19.8%-22.9% pts

Operating margin

-80.0%-41.4% pts

Net margin

-72.7%-44.8% pts

FCF margin

-48.3%-4.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$7.2M$7.2M$6.2M$5.9M$14.9M
Net Income$-5.2M$-5.2M$-7.4M$-9.2M$-4.1M
EBITDA$-4.3M$-4.3M$-6.3M$-6.0M$-3.1M
EPS-0.01-0.01-0.01-0.02-0.01
Gross Margin-19.8%-19.8%-34.9%17.4%3.1%
Operating Margin-80.0%-80.0%-113.9%-104.9%-38.6%
Net Margin-72.7%-72.7%-119.1%-157.9%-27.9%
Balance Sheet
Debt/Equity0.000.000.080.030.07
Current Ratio2.342.34———
Cash Flow
Free Cash Flow$-3.5M$-3.5M$-4.7M$-8.0M$-6.5M
Returns
ROE-21.8%-21.8%-27.4%-27.5%-25.8%
Valuation
P/B0.580.580.540.392.58
Growth & Yield
Revenue Growth16.1%16.1%5.5%-60.7%—
EPS Growth36.8%36.8%30.9%-103.7%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -53.7%

Total return

-53.7%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.01 → -0.01

Residual

-53.7%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-53.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.